Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Koranyi National Institute of Tbc and Pulmonology
Budapest, Hungary
- Koranyi National Institute of Tbc and Pulmonologyhhy
Budapest, Hungary
- University of Debrecen, Medical and Health Science Center, Department of Pulmonology
Debrecen, Hungary
- Szabolcs-Szatmar-Bereg County Hospitals and University Teaching Hospital, Department of Pulmonology
Nyíregyháza, Hungary
- Medical Center of the University of Pecs, 1st Department of Internal Medicine
Pécs, Hungary
- Hetenyi Geza Hospital
Szolnok, Hungary
- Hospital General Universitario de Alicante
Alicante, Spain
- Hospital Clinic I Provincial de Barcelona
Barcelona, Spain
- Hospital Universitario Quiron-Dexeus (ior)
Barcelona, Spain
- University Hospital Vall D'Hebron
Barcelona, Spain
- Hospital Universitario Lucus Augusti
Lugo, Spain
- General University Hospital Gregorio Maranon
Madrid, Spain
- Hospital Puerta de Hierro
Madrid, Spain
- University Hospital Foundation Jimenez Diaz
Madrid, Spain
- University Hospital la Paz
Madrid, Spain
- Hospital Regional Universitario
Málaga, Spain
- University Hospital Virgen de Valme
Seville, Spain
- Chu Xeral
Vigo, Spain
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- City of Hope Medical Group
Pasadena, California, United States
- Cancer Specialists of North Florida-Fleming Island
Fleming Island, Florida, United States
- Northwest Georgia Oncology Centers, P.C.
Marietta, Georgia, United States
- James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Oncology Hermatology Care, Inc.
Cincinnati, Ohio, United States
- Northwest Ccop Kaiser Permanente
Portland, Oregon, United States
- Penn State Hershey Cancer Institute
Hershey, Pennsylvania, United States
- Tennessee Oncology
Chattanooga, Tennessee, United States
- Tennessee Cancer Specialists
Knoxville, Tennessee, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2015
- Primary completion
- 15 May 2017
- Completion
- 15 May 2017
- Last update posted
- 25 Jun 2024
- Registered enrollment
- 135
- Registry id
- NCT02200757
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.